Three decades of low-dose methotrexate in rheumatoid arthritis: Can we predict toxicity?
作者： Vasco C. Romão , Aurea Lima , Miguel Bernardes , Helena Canhão , João Eurico Fonseca
DOI: 10.1007/S12026-014-8564-6
关键词: Pharmacology 、 Medicine 、 Pharmacogenomics 、 Intensive care medicine 、 Methotrexate 、 Toxicity 、 Drug withdrawal 、 Arthritis 、 Drug 、 Rheumatoid arthritis 、 Pharmacogenetics
摘要: … , methotrexate (MTX) has become the mainstay of rheumatoid arthritis (RA) therapeutic arsenal. While being used in … and during treatment with low-dose MTX, as it has been associated …
springer.com
sci-hub.se 
researchgate.net 参考文章(171)
K Visser, D M F M van der Heijde, Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature. Clinical and Experimental Rheumatology. ,vol. 27, pp. 1017- 1025 ,(2009)
Balk Ra, Katz Rs, Golden Mr, Golden He, The relationship of preexisting lung disease to the development of methotrexate pneumonitis in patients with rheumatoid arthritis. The Journal of Rheumatology. ,vol. 22, pp. 1043- 1047 ,(1995)
Yvonne Wettergren, Elisabeth Odin, Göran Carlsson, Bengt Gustavsson, MTHFR, MTR, and MTRR polymorphisms in relation to p16INK4A hypermethylation in mucosa of patients with colorectal cancer. Molecular Medicine. ,vol. 16, pp. 425- 432 ,(2010) , 10.2119/MOLMED.2009.00156
B. F. Leeb, E. Ogris, H. Schweitzer, G. Witzmann, I. Andel, J. S. Smolen, A. Studnicka-Benke, Folic acid and cyanocobalamin levels in serum and erythrocytes during low-dose methotrexate therapy of rheumatoid arthritis and psoriatic arthritis patients. Clinical and Experimental Rheumatology. ,vol. 13, pp. 459- 463 ,(1995)
Takao Fujii, Yasuo Ohosone, Tsuneyo Mimori, Michito Hirakata, Yasuo Ikeda, Yutaka Okano, Masashi Akizuki, Hideto Kameda, Nobuaki Hama, Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis The Journal of Rheumatology. ,vol. 24, pp. 2299- 2303 ,(1997)
T Karger, H Frenzel, G Herborn, R Rau, Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate. The Journal of Rheumatology. ,vol. 16, pp. 489- 493 ,(1989)
P. Dale, R. J. R. Mckendry, Adverse effects of low dose methotrexate therapy in rheumatoid arthritis. The Journal of Rheumatology. ,vol. 20, pp. 1850- 1856 ,(1993)
Jacek Szechiński, Jerzy Swierkot, Methotrexate in rheumatoid arthritis. Pharmacological Reports. ,vol. 58, pp. 473- 492 ,(2006)
Krajinovic M, Damnjanovic T, Damjanov N, Pejnovic N, Radunovic G, Lukovic L, Jekic B, Popovic B, Maksimovic N, Novakovic I, Milasin J, Milic, Bunjevacki, Association of dihydrofolate reductase (DHFR) -317AA genotype with poor response to methotrexate in patients with rheumatoid arthritis. Clinical and Experimental Rheumatology. ,vol. 30, pp. 178- ,(2012)
L. B. A. Van De Putte, M. E. C. Jeurissen, A. M. T. Boerbooms, P. J. S. M. Kerstens, J. H. Fast, K. J. M. Assmann, Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis. An analysis of ten cases. The Journal of Rheumatology. ,vol. 19, pp. 867- 871 ,(1992)